相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Pharmacokinetics of meropenem in burn patients with infections caused by Gram-negative bacteria: Are we getting close to the right treatment?
Silvia Corcione et al.
JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE (2020)
Therapeutic monitoring of vancomycin for serious -methicillin-resistant Staphylococcus aureus infections: A revised consensus guideline and review by the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists
Michael J. Rybak et al.
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY (2020)
After standard dosage of piperacillin plasma concentrations of drug are subtherapeutic in burn patients
Katharina Olbrisch et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2019)
Characterization of variables for potential impact on vancomycin pharmacokinetics in thermal or inhalation injury
Katie Elder et al.
BURNS (2018)
381 Pharmacokinetics and Pharmacodynamics of Voriconazole in Burn Patients: A Case Series
T E Schlotman et al.
Journal of Burn Care & Research (2018)
Pharmacokinetics of colistin methanesulfonate (CMS) in burn patients
Silvia Corcione et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2017)
A prospective study evaluating tobramycin pharmacokinetics and optimal once daily dosing in burn patients
Colin Lee et al.
BURNS (2017)
The biochemical alterations underlying post-burn hypermetabolism
Christopher Auger et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2017)
Adequacy of a hospital-wide standard dose of 7 mg/kg bodyweight gentamicin sufficient to achieve an adequate prophylactic maximum serum concentration (Cmax) in burn patients undergoing surgical burn wound treatment
Lennaert C. P. Borra et al.
BURNS (2016)
Intravenous Antibiotic and Antifungal Agent Pharmacokinetic-Pharmacodynamic Dosing in Adults with Severe Burn Injury
Jason M. Cota et al.
CLINICAL THERAPEUTICS (2016)
Safety and Efficacy of Intermittent Intravenous Administration of High-Dose Micafungin
Dionysis Neofytos et al.
CLINICAL INFECTIOUS DISEASES (2015)
Framework for optimisation of the clinical use of colistin and polymyxin B: the Prato polymyxin consensus
Roger L. Nation et al.
LANCET INFECTIOUS DISEASES (2015)
Micafungin at a standard dosage of 100 mg/day achieves adequate plasma exposure in critically ill patients with severe burn injuries
M. J. Asensio et al.
INTENSIVE CARE MEDICINE (2015)
Cytochrome P450 enzyme regulation by glucocorticoids and consequences in terms of drug interaction
Petra Matoulkova et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2014)
Introduction to Drug Pharmacokinetics in the Critically Ill Patient
Brian S. Smith et al.
CHEST (2012)
Serum Vancomycin Levels Resulting From Continuous or Intermittent Infusion in Critically Ill Burn Patients With or Without Continuous Renal Replacement Therapy
Kevin S. Akers et al.
JOURNAL OF BURN CARE & RESEARCH (2012)
Pharmacokinetics of Colistin and Colistimethate Sodium After a Single 80-mg Intravenous Dose of CMS in Young Healthy Volunteers
W. Couet et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2011)
Long-Term Persistance of the Pathophysiologic Response to Severe Burn Injury
Marc G. Jeschke et al.
PLOS ONE (2011)
Augmented Renal Clearance Implications for Antibacterial Dosing in the Critically Ill
Andrew A. Udy et al.
CLINICAL PHARMACOKINETICS (2010)
Regulation of drug-metabolizing cytochrome P450 enzymes by glucocorticoids
Zdenek Dvorak et al.
DRUG METABOLISM REVIEWS (2010)
Pharmacokinetic evaluation of linezolid in patients with major thermal injuries
A. M. Lovering et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2009)
Causes of Mortality by Autopsy Findings of Combat Casualties and Civilian Patients Admitted to a Burn Unit
Ruben Gomez et al.
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS (2009)
Pharmacokinetic evaluation of single-dose intravenous daptomycin in patients with thermal burn injury
John F. Mohr et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Incidence of systemic fungal infection and related mortality following severe burns
Clinton K. Murray et al.
BURNS (2008)
Influence of burns on pharmacokinetics and pharmacodynamics of drugs used in the care of burn patients
Benoit Blanchet et al.
CLINICAL PHARMACOKINETICS (2008)
Pharmacokinetic changes in critical illness
Bradley A. Boucher et al.
CRITICAL CARE CLINICS (2006)
Cytochrome P450 3A4 activity after surgical stress
CE Haas et al.
CRITICAL CARE MEDICINE (2003)
分享论文
